(Q48135236)

9 February 2018

title

Deprenyl rescues dopaminergic neurons in organotypic slice cultures of neonatal rat mesencephalon from N-methyl-D-aspartate toxicity (English)

1 reference

9 February 2018

1 reference

Shimazu S

1

1 reference

9 February 2018

Katsuki H

series ordinal

2

1 reference

9 February 2018

Akaike A

series ordinal

3

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 July 1999

1 reference

9 February 2018

European Journal of Pharmacology

published in

1 reference

9 February 2018

volume

377

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

29-34

1 reference

9 February 2018

The concept of astrocyte-kinetic drug in the treatment of neurodegenerative diseases: evidence for L-deprenyl-induced activation of reactive astrocytes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Sequential changes in activities of superoxide dismutase and catalase in brain regions and liver during (-)deprenyl infusion in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Micromolar L-glutamate induces extensive apoptosis in an apoptotic-necrotic continuum of insult-dependent, excitotoxic injury in cultured cortical neurones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Effect of L-deprenyl, its structural analogues and some monoamine oxidase inhibitors on dopamine uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Glutamate neurotoxicity in mesencephalic dopaminergic neurons in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

L-deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Deprenyl decreases an endogenous parkinsonism-inducing compound, 1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice: in vivo and in vitro studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Selegiline treatment after transient global ischemia in gerbils enhances the survival of CA1 pyramidal cells in the hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Excitatory amino acids as a final common pathway for neurologic disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Co-culture with the striatum attenuates N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of rat mesencephalic slice cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

L-deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Effect of deprenyl on the progression of disability in early Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

R-deprenyl and R-2-heptyl-N-methylpropargylamine prevent apoptosis in cerebellar granule neurons induced by cytosine arabinoside but not low extracellular potassium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

(-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

The effect of deprenyl (selegiline) on the natural history of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Effect of MPTP and l‐Deprenyl on Antioxidant Enzymes and Lipid Peroxidation Levels in Mouse Brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

Hydroxyl and peroxyl radical trapping by the monoamine oxidase-B inhibitors deprenyl and MDL 72,974A: implications for protection of biological substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900414-8

10.1016/S0014-2999(99)00414-8

7 January 2021

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018